Lixte Biotechnology

+$0.15 (+5.62%) Today
-$0.07 (-2.48%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell LIXT and other stocks, options, and ETFs commission-free!

About LIXT

Lixte Biotechnology Holdings, Inc. operates as a drug discovery company, that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The firm focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development.

CEO
John S. Kovach
Employees
4
Headquarters
East Setauket, New York
Founded
2005

LIXT Key Statistics

Market Cap
37.03M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.39K
High Today
$2.84
Low Today
$2.63
Open Price
$2.74
Volume
46.52K
52 Week High
$7.17
52 Week Low
$2.39

LIXT Earnings

Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 18, Pre-Market

You May Also Like

OSMT
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure